Vitamin K's recommended dietary allowance (RDA) is based on the hepatic requirement for
clotting factor synthesis, but substantial concentrations of undercarboxylated extra-hepatic Gla-
proteins are found in the circulation of non-supplemented individuals. This suggests that
vitamin K intake above the RDA is required for an optimal extra-hepatic
vitamin K status. Circulating uncarboxylated
osteocalcin (ucOC) and desphospho-uncarboxylated
matrix Gla-protein (dp-ucMGP) are considered markers of the
vitamin K status in bone and the vasculature, respectively. We measured these markers in 896 samples of healthy volunteers and defined target groups for
vitamin K supplementation based on increased levels indicative of tissue-specific
vitamin K deficiency. We studied the response to
vitamin K supplements at different states of
vitamin K deficiency by measuring the circulating dp-ucMGP level in samples from two short-term trials on
menaquinone-7 (MK-7,
vitamin K2) supplementation in 42 children and 68 adults. Children had high ucOC levels (3.4-96.9 ng ml(-1)); other age groups had values in the range of 1.5-5.0 ng ml(-1). From the age of 40 years, dp-ucMGP levels gradually increased. Children and adults with more pronounced
vitamin K deficiency gave the highest responses to MK-7 supplementation. Children and adults above 40 years showed the largest tissue-specific
vitamin deficiency and accordingly may benefit from MK-7 supplementation to improve their extra-hepatic
vitamin K status.